Skip to main content
. 2014 Nov 12;9(11):e112614. doi: 10.1371/journal.pone.0112614

Figure 2. Effect of erucin on DMBA induced alterations in hepatic phase I enzymes (A) NADH-cytochrome b5 reductase, (B) NADPH-cytochrome P450 reductase, (C) Cytochrome b5, (D) Cytochrome P450, (E) Cytochrome P420.

Figure 2

Treatment groups with same alphabet show no significant difference, while the groups with different alphabets show significant difference at p≤0.05. Error bars indicate SEM (n = 6).